Skip to content

High Frequency Jet Ventilation for Percutaneous Interventional Radiology

High Frequency Jet Ventilation for Percutaneous Interventional Radiology

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02813005
Enrollment
108
Registered
2016-06-24
Start date
2016-07-31
Completion date
2018-08-31
Last updated
2017-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Percutaneous Tumor Ablation

Keywords

High frequency jet ventilation

Brief summary

Evaluate benefits of High Frequency Jet Ventilation compare to standard ventilation during general anesthesia in patient undergoing peri diaphragmatic percutaneous tumor ablation. The investigators hypothesis that procedure is shorter and more accurate in High Frequency Jet Ventilation group reducing target movement induced by ventilation.

Interventions

PROCEDUREJet ventilation group

MONSOON III™ (Acutronic Medical System AG®, SEBAC) with Double lumen catheter 12CH (Acutronic Medical System AG®, SEBAC)

PROCEDUREStandard ventilation group

apnea made by the anesthesiologist to the request of the radiologist

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* use of percutaneous ablation tumor techniques (\<3cm) for inferior lung, superior kidney, superior liver or adrenal gland lesion

Exclusion criteria

* Severe chronic obstructive pulmonary disease * Recent pneumothorax (one month) * Recent thoracic surgery (one month) * Body Mass Index \> 40

Design outcomes

Primary

MeasureTime frameDescription
Time to hit the targetduring the procedureEstimated the time for a puncture needle under High Frequency Jet Ventilation compared to the conventional mode of mechanical ventilation

Countries

France

Contacts

Primary ContactSandra PETIOT, MD
Sandra.Petiot@chru-strasbourg.fr+33 369550443

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026